Skip to main content
search

Late Clinical

Sign up

Latest resources

Featured resource

Upcoming late clinical webinars

Latest late clinical blogs

Meet our experts at the following events

Conference

JSCPT 2025

December 5 - 6, 2025 – Tokyo, Japan
Conference

JPM 2026 44th Annual Healthcare Conference & Biotech Showcase

January 12 - 16, 2026 – San Francisco, CA
Conference

DIA RSIDM 2026

February 2 - 4, 2026 – Bethesda North Marriott Hotel & Conference Center, North Bethesda, MD – Booth 202

All late clinical resources

Physiologically-Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and Challenges

Certara Products - Simcyp, Clinical Pharmacology, Model Informed Drug Development, Modeling and Simulation - PBPK, Publication

PHUSE APAC Connect 2026

Certara Products - Pinnacle 21, Clinical Trials, Data Standards, SDTM, Conference

From Insight to Impact: Certainty EMEA 2025

Certara Products, Certara Services, Blog

ACoP 2025 Insights: Scaling the Future of QSP Modeling with Certara IQ™

Certara Products, Certara Products - Certara IQ, Certara Products - Phoenix, Certara Services, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Blog

Validation in clinical data management: MacroGenics® Optimizes Validation and Issue Management with Pinnacle 21® Enterprise

Certara Products - Pinnacle 21, Oncology/Hematology, Case Study

Supporting KalVista’s NDA Submission for a Novel HAE Treatment​

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation - PK/PD, Oncology/Hematology, Pharmacometrics, Therapeutic Specialties, Case Study

Supporting Ionis’ Donidalorsen BLA with Biomarker​ HAE Attack Rate Modeling

Cell and Gene Therapy, Certara Services, Clinical Pharmacology, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation - PK/PD, Oncology/Hematology, Pharmacometrics, Rare and Neglected Diseases, Therapeutic Specialties, Case Study

Towards new approach methodologies for biological therapeutics: a novel model-informed metric to assess immunogenicity risk

Certara Products - Certara IQ, Certara Services, Modeling and Simulation - QSP, New Approach Methodologies (NAMs), Publication

Failure to Launch: Building Smarter Strategies to Get the Right Drug to the Right Patient

Certara Services, Drug Development, Webinar

Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation

Cardiovascular, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation - PK/PD, Publication

Delivering on Deadline: Navigating Regulatory Submissions with Pharmacometrics Insights

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Webinar

Empowering the PK Community: Insights from the Phoenix® User Events

Modeling and Simulation - PK/PD, Blog
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.